1,3,4-oxadiazole has been researched along with quinoxalines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, D; Koketsu, M; Ninomiya, M; Nishina, A; Ono, Y; Sonawane, AD; Tanaka, K; Udagawa, T | 1 |
| Kaneko, D; Koketsu, M; Ninomiya, M; Nishina, A; Ono, Y; Sonawane, AD; Tanaka, K; Yoshikawa, R | 1 |
| Asgari, MS; Barzegari, E; Gulçin, İ; Larijani, B; Mahdavi, M; Mirzazadeh, R; Mohammadi-Khanaposhtani, M; Pedrood, K; Rahmani, H; Rastegar, H; Sherafati, M; Taslimi, P; Üç, EM | 1 |
3 other study(ies) available for 1,3,4-oxadiazole and quinoxalines
| Article | Year |
|---|---|
Design and synthesis of quinoxaline-1,3,4-oxadiazole hybrid derivatives as potent inhibitors of the anti-apoptotic Bcl-2 protein.
Topics: Antineoplastic Agents; Apoptosis; Density Functional Theory; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oxadiazoles; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oxadiazoles; Quinoxalines; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2020 |
New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies.
Topics: Carbonic Anhydrase Inhibitors; Cholinesterase Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Models, Molecular; Molecular Docking Simulation; Oxadiazoles; Quinoxalines; Structure-Activity Relationship | 2021 |